COMMUNIQUÉS West-GlobeNewswire
-
Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer
30/06/2026 -
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
30/06/2026 -
CBDWatchlist.com Introduces 2026 CBD Gummies and CBD Oil Transparency Review Initiative
30/06/2026 -
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
30/06/2026 -
Breckenridge Distillery Earns Double Gold for Rum Cask Finish at New York International Spirits Competition
30/06/2026 -
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
30/06/2026 -
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
30/06/2026 -
Travel Fatigue Treatments Gain Traction as Summer Travel Increases, Says Prana IV Therapy
30/06/2026 -
Biosphere Expands Biomanufacturing Platform with NovoNutrients Acquisition
30/06/2026 -
Celebrate the Fourth—Without Damaging Your Hearing or Losing Your Voice
30/06/2026 -
FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience
30/06/2026 -
Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
30/06/2026 -
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
30/06/2026 -
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026 -
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
30/06/2026 -
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30/06/2026 -
Psychemedics Releases 2026 Education Insights Report
30/06/2026 -
Exicure Announces Board and Committee Changes
30/06/2026 -
Artelo Biosciences Presents Evidence for a Common Lipid-Signaling Link Across Multiple Potential Indications for Its FABP5 Inhibitor Platform at ICRS 2026
30/06/2026
Pages